May 5, 2025
Showing 5311 - 5320 of 8689 results
February 26, 2016
New VTE Guidelines Favor NOACs Over Warfarin
March 2, 2015
New, Limited Rx Coming for Orthostatic Hypotension
October 1, 2025
New, Revised Resources for a Medical Director’s Roles
Newly Approved Treatment in Alzheimer’s Disease
Join us for a live webinar June 24 at 12:00 PM EST and be among the first to learn about a newly approved treatment for Alzheimer’s disease! In collaboration with Alpha Cognition, this edition will educate on the differentiation of the newly approved treatment based on its underlying technology and mechanism of action, as well as review the treatment’s efficacy and safety established from clinical trials and real-world evidence. The speakers, including Michael McFadden, Chief Executive Officer at Alpha Cognition, will enable participants to explore unmet needs in the treatment of Alzheimer’s Disease and learn about a new treatment. Register now.
US-ZUNV-00069 V1
Newly Approved Treatment in Alzheimer’s Disease
Join us for a live webinar July 29 at 12:00 PM EST and be among the first to learn about a newly approved treatment for Alzheimer’s disease! In collaboration with Alpha Cognition, this edition will educate on the differentiation of the newly approved treatment based on its underlying technology and mechanism of action, as well as review the treatment’s efficacy and safety established from clinical trials and real-world evidence. The speakers, including Michael McFadden, Chief Executive Officer at Alpha Cognition, will enable participants to explore unmet needs in the treatment of Alzheimer’s Disease and learn about a new treatment. Register now.
US-ZUNV-00069 V1
July 31, 2015
News From the ASSOCIATION
July 2, 2015
News From the Association
December 22, 2015
News From the ASSOCIATION
October 30, 2015